Literature DB >> 6454817

Diagnostic laparoscopy: role in management of acute pelvic pain.

A Murphy, J Fliegner.   

Abstract

Laparoscopy is valuable in the definitive diagnosis of pelvic pain of uncertain aetiology. A clinical diagnosis of pelvic pain was made in 67 patients, but was confirmed by laparoscopy in only 34. In 36 patients in whom a clinical diagnosis of ectopic pregnancy had been made this was confirmed at laparoscopy in 21, while six of 26 positive laparoscopic diagnoses of ectopic pregnancy were unsuspected clinically. Acute pelvic inflammatory disease was diagnosed correctly on clinical grounds in only eight of 22 patients; in the other 16 patients the diagnosis was first made at laparoscopy. In these 16 patients there was poor correlation with the bacteriological results of cervical smears and cultures. Of 30 patients in whom a preoperative clinical diagnosis had not been made, laparoscopy showed normal pelvic viscera in 12. Similarly, in another eight of the 68 patients thought to have organic pelvic pathology on clinical grounds, the laparoscopic findings were normal. Apart from establishing a definitive diagnosis, laparoscopy has been found to be a safe procedure, and one of considerable cost effectiveness in terms of hospital stay.

Entities:  

Mesh:

Year:  1981        PMID: 6454817     DOI: 10.5694/j.1326-5377.1981.tb135835.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

Review 1.  Chronic pelvic pain: clinical dilemma or clinician's nightmare.

Authors:  A F Ghaly; P W Chien
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

2.  The use of laparoscopy in the management of right iliac fossa pain.

Authors:  P J Clarke; L J Hands; M H Gough; M G Kettlewell
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

3.  Role of laparoscopy in evaluation of chronic pelvic pain.

Authors:  Shripad Hebbar; Chander Chawla
Journal:  J Minim Access Surg       Date:  2005-09       Impact factor: 1.407

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.